[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"thrombocytosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:thrombocytosis":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":4,"maxAge":4,"enrollmentInfo":15,"targetDuration":4,"studyType":18,"phases":4,"briefSummary":19,"conditions":20,"keywords":23,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100111972",false,"NCT00722527","Molecular Biology of Polycythemia and Thrombocytosis","Inclusion Criteria:\n\n1. Subjects with an elevated hemoglobin concentration (\\>18 in males and \\>16 in females)\n2. Subjects with an elevated platelet count (\\>450,000)\n\nExclusion Criteria:\n\n1. Subjects who have a known acquired cause of polycythemia and thrombocytosis\n2. Subjects with heart disease, left to right heart shunt or severe pulmonary disease","ALL",{"count":16,"type":17},200,"ESTIMATED","OBSERVATIONAL","Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.",[21,22],"Polycythemia","Thrombocytosis",[24,21,25,26,27,28,22,29],"Primary Familial and Congenital Polycythemia","Molecular Biology","Genetics","Erythropoiesis","EPOR mutation","Hypoxia","RECRUITING","2026-03-05",{"date":33,"type":34},"2026-03-09","ACTUAL",{"date":36,"type":4},"2006-07",{"date":38,"type":17},"2028-07",{"name":40,"class":41},"University of Utah","OTHER",""]